COMMUNIQUÉS West-GlobeNewswire

-
Amicus Therapeutics and Brammer Bio, a part of Thermo Fisher Scientific, Enter Strategic Gene Therapy Development and Manufacturing Collaboration
01/07/2019 -
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Progenics Shareholders Vote “FOR” ALL of Progenics’ Director Nominees
01/07/2019 -
Axovant Appoints David Nassif as Chief Financial Officer and Expands Board of Directors
01/07/2019 -
Share buy-back week 26/2019
01/07/2019 -
Cerecor Announces Positive Final Results of CERC-301 in the Treatment of Neurogenic Orthostatic Hypotension (OH)
01/07/2019 -
LHC Group Continues Commitment to Clinical Quality With Addition of Tricia Nguyen as Chief Medical Officer
01/07/2019 -
Parallax Health Sciences Announces Directive in the Company's Artificial Intelligence Program
01/07/2019 -
Arrayit Corporation Approved for Electronic Medicare Reimbursement from the Centers for Medicare and Medicaid Services
01/07/2019 -
Affimed Added to the Russell 2000®, 3000® and Microcap Indexes
01/07/2019 -
Philips Foundation publishes 2018 Annual Report
01/07/2019 -
Announcement no. 06/2019 - The French Ministry of Health has announced a price reform within Ostomy Care, Continence Care and Wound Care
01/07/2019 -
Herantis Pharma publishes newsletter for May-June
01/07/2019 -
Nanobiotix announces new organizational structure as the company enters its next stage after first european market approval
01/07/2019 -
Nanobiotix annonce une nouvelle équipe de direction à la suite de son autorisation de mise sur le marché européen
01/07/2019 -
Oxurion NV Reports Positive Topline Phase 1 Results with THR-149, a novel, potent plasma kallikrein inhibitor for the treatment
01/07/2019 -
ESPERITE NV (ESP) WITH CRYOSAVE CONFIRMS THE SAFETY OF ALL THE SAMPLES STORED AND THANKS THE 260’000 FAMILIES FOR THEIR TRUST AND CONFIDENCE.
01/07/2019 -
ESPERITE NV (ESP) AVEC CRYOSAVE CONFIRME LA SÉCURITÉ DE TOUS LES ÉCHANTILLONS STOCKÉS ET REMERCIE LES 260'000 FAMILLES POUR LEUR CONFIANCE.
01/07/2019 -
Basilea extends phase 2 study with derazantinib in intrahepatic bile duct cancer (iCCA) to include patients with FGFR2 gene mutations or amplifications
01/07/2019 -
Genkyotex’s GKT831 Prevents Multiple Complications of Portal Hypertension in Preclinical Model
01/07/2019
Pages